Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Petersen

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
BMJ (Clinical Research Ed.)|July 9, 2020
Is stratified shielding from covid-19 feasible and ethical?Irene Petersen
The Journal of Infection|June 19, 2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coliMark Melzer, Irene Petersen
Pharmacoepidemiology and Drug Safety|May 21, 2009
Creating medical and drug code lists to identify cases in primary care databasesShreya Davé, Irene Petersen
Clinical Epidemiology|October 29, 2020
Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey DataIrene Petersen, Andrew Phillips
The Journal of Infection|May 15, 2012
A re-audit of outcomes in patients with ESBL producing Escherichia coli bacteraemiaMark Melzer, Irene Petersen
JAMA Internal Medicine|March 3, 2015
Antidepressant dose and risk of deliberate self-harm: is it the dose or the indication?Irene Petersen, Irwin Nazareth
Clinical Epidemiology|November 5, 2025
Regression Discontinuity Designs in Epidemiology: A Practical GuideAidan G O'Keeffe, Irene Petersen
The Journal of Antimicrobial Chemotherapy|September 14, 2007
Antibacterial prescribing in primary careIrene Petersen, Andrew C Hayward,
Pharmacoepidemiology and Drug Safety|February 19, 2016
Backdating of events in electronic primary health care data: should one censor at the date of last data collectionCormac J Sammon, Irene Petersen
Rheumatology (Oxford, England)|March 12, 2011
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsLaurence Fardet, Irene Petersen, Irwin Nazareth
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
BMJ (Clinical Research Ed.)|July 9, 2020
Is stratified shielding from covid-19 feasible and ethical?Irene Petersen
The Journal of Infection|June 19, 2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coliMark Melzer, Irene Petersen
Pharmacoepidemiology and Drug Safety|May 21, 2009
Creating medical and drug code lists to identify cases in primary care databasesShreya Davé, Irene Petersen
Clinical Epidemiology|October 29, 2020
Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey DataIrene Petersen, Andrew Phillips
The Journal of Infection|May 15, 2012
A re-audit of outcomes in patients with ESBL producing Escherichia coli bacteraemiaMark Melzer, Irene Petersen
JAMA Internal Medicine|March 3, 2015
Antidepressant dose and risk of deliberate self-harm: is it the dose or the indication?Irene Petersen, Irwin Nazareth
Clinical Epidemiology|November 5, 2025
Regression Discontinuity Designs in Epidemiology: A Practical GuideAidan G O'Keeffe, Irene Petersen
The Journal of Antimicrobial Chemotherapy|September 14, 2007
Antibacterial prescribing in primary careIrene Petersen, Andrew C Hayward,
Pharmacoepidemiology and Drug Safety|February 19, 2016
Backdating of events in electronic primary health care data: should one censor at the date of last data collectionCormac J Sammon, Irene Petersen
Rheumatology (Oxford, England)|March 12, 2011
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsLaurence Fardet, Irene Petersen, Irwin Nazareth
Pageof 26